Pharmaceutical Compositions of a Kinase Inhibitor
The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
14.12.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions. |
|---|---|
| AbstractList | The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions. |
| Author | CHEN, Tzu-Yuan LIEJANTO, Iswadi |
| Author_xml | – fullname: LIEJANTO, Iswadi – fullname: CHEN, Tzu-Yuan |
| BookMark | eNrjYmDJy89L5WQwDMhILMpNTE4tLclMTsxRcM7PLcgvzizJzM8rVshPU0hU8M7MSyxOVfDMy8hMyizJL-JhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBUCz8lJL4kODjQyMjI0tLQwNLBwNjYlTBQBDxC5V |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2023398108A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2023398108A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:54:08 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2023398108A13 |
| Notes | Application Number: US202118035355 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231214&DB=EPODOC&CC=US&NR=2023398108A1 |
| ParticipantIDs | epo_espacenet_US2023398108A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20231214 |
| PublicationDateYYYYMMDD | 2023-12-14 |
| PublicationDate_xml | – month: 12 year: 2023 text: 20231214 day: 14 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | Exelixis, lnc |
| RelatedCompanies_xml | – name: Exelixis, lnc |
| Score | 3.4989288 |
| Snippet | The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Pharmaceutical Compositions of a Kinase Inhibitor |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231214&DB=EPODOC&locale=&CC=US&NR=2023398108A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAfYZgOLADJiYbJKqa2KYZqxrkWSerJsEak1YmqUZpIBPvPH1M_MINfGKMI1gYsiB7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuatDeMbCxYmRooubiZOsa4O_i76zm7GwbGqzmFwSWM7a0MDSwcAT2lVhBDWnQSfuuYU6gfSkFyJWKmyADWwDQvLwSIQam1DxhBk5n2N1rwgwcvtApbyATmvuKRRgMAzKQB6AVQHkZtuZKIT9NIVHBOzMPWCspeOZlZCYBs2qRKIOym2uIs4cu0O54uFfjQ4ORHWosxsCSl5-XKsGgAGxIGaQBezfA9pyJiYGxZZKFUaJ5krF5Yoq5qaWBqYEkgww-k6TwS0szcIG4oGUahiYyDCwlRaWpssDKtiRJDhxGAILkgTY |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjU-qpJouBGhLAUOxFgoobZQYqnprWEppCQGmhbj33d2U7Sn3jYzyb6Sb-eb2dlZgGf0GVCOAIwTkkpEyVTJoHoiUcYmzF4mL3nFGz_oeTPyPtfmDfiq38LwOqE_vDgiIipBvFf8vF7_B7Ecnlu5faE5ispXN7IccecdI1npKkR0-tYgnDgTW7RtazYVgw-uU01DkY039JWOdFafl5Gnzz57l7LeNyruGRyH2F9RnUMjLdrQsuu_19pw4u-uvLG5Q9_2ApRwtR-AFhiW65wrocyEWBjlBVolYViscopQ3VzCkzuIbE_CsRd_S13MpvsTVa-gWZRFeg0CEik5Q-8G-RwhsmpSoxvrVNXjpa6ZsibfQOdQT7eH1Y_Q8iJ_vBgPg9EdnDIVS9lQSAea1eY7vUfDW9EHvl-_tlOEIw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pharmaceutical+Compositions+of+a+Kinase+Inhibitor&rft.inventor=LIEJANTO%2C+Iswadi&rft.inventor=CHEN%2C+Tzu-Yuan&rft.date=2023-12-14&rft.externalDBID=A1&rft.externalDocID=US2023398108A1 |